Drug Reference Vocabulary - Multum License Agreement

공공데이터포털

License for the Drug Abuse Warning Network\'s Drug Reference Vocabulary (DRV), a classification system for the substances collected by DAWN that is based on the Multum Lexicon, © 2012 Lexi-Comp, Inc. and/or Cerner Multum, Inc. to meet DAWN\'s unique requirements. The Lexicon classification was modified to meet DAWN\'s unique requirements.

Glossary of DAWN Terms, 2011 Update

공공데이터포털

This glossary defines terms used in data collection activities, analyses, and publications associated with the emergency department (ED) component of the Drug Abuse Warning Network (DAWN). The glossary is updated to reflect terms and conventions applicable in the 2011 data collection year.

Drug Abuse Warning Network, 2010: Glossary

공공데이터포털

This glossary defines terms used in data collection activities, analyses, and publications associated with the emergency department (ED) component of the Drug Abuse Warning Network (DAWN). The glossary is updated to reflect terms and conventions applicable in the 2010 data collection year.

Drug Abuse Warning Network Methodology Report, 2011 Update

공공데이터포털

This publication describes the methodologies used by the Drug Abuse Warning Network (DAWN), to collect, prepare, and analyze information on drug-related emergency department (ED) visits in the United States. The methods described here were initiated in 2004 and are current as of 2011.

Drug Abuse Warning Network, 2010: Methodology Report

공공데이터포털

This publication describes the methodologies used by the Drug Abuse Warning Network (DAWN), to collect, prepare, and analyze information on drug-related emergency department (ED) visits in the United States. The methods described here were initiated in 2004 and are current as of 2010.

Drug Abuse Warning Network (DAWN): Findings From Drug-Related Emergency Department Visits, 2021

공공데이터포털

An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related ED visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (4) the identification of drugs new to DAWN’s Drug Reference Vocabulary.Clickhereto view the 2021 final report.

The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits

공공데이터포털

This Drug Abuse Warning Network (DAWN) short report summarizes key findings about drug-related emergency department visits between 2004 and 2010. The report includes data for illicit drugs, alcohol, and prescription and over-the counter medications. For medications, the report looks at misuse and abuse, adverse reactions, and accidental ingestion of drugs by children.

The DAWN Report: Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits

공공데이터포털

This Drug Abuse Warning Network (DAWN) short report summarizes key findings about drug-related emergency department visits between 2004 and 2011. The report includes data for illicit drugs, alcohol, and prescription and over-the counter medications. For medications, the report looks at misuse and abuse, adverse reactions, and accidental ingestion of drugs by children.

RxTerms

공공데이터포털

RxTerms is a drug interface terminology derived from RxNorm for prescription writing or medication history recording (e.g. in e-prescribing systems, PHRs). RxTerms is derived only from the non-proprietary content of RxNorm, which is developed and maintained by the U.S. National Library of Medicine. No fee or license is required to use the RxTerms data. Technical documentation at https://wwwcf.nlm.nih.gov/umlslicense/rxtermApp/rxTermFileStructure.cfm

Drug Abuse Warning Network (DAWN): National Estimates from Drug-Related Emergency Department Visits, 2024

공공데이터포털

This report presents data on national estimates of substance-related ED visits from 60 participating DAWN hospitals in 2024. The data includes (1) all drug-related ED visits, (2) the top substances involved in drug-related ED visits, (3) opioid-related ED visits by type, and (4) polysubstance-related ED visits.